1. Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (J.C., X.C.).
2. BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, United Kingdom (A.F.D.).
3. Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville (R.M.C.).
4. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (C.L.L., F.E.).
5. Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN (S.J.T.).
6. Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, University of Alabama, Birmingham (T.D.).
7. Research Institute of the McGill University Health Centre, McGill University, Montreal, Canada (R.M.T.).
8. Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (J.-G.W.).